LPL Financial’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

LPL Financial’s Portfolio RVLP Stock Details RVLP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-21,210	Closed	-$1.84K	–	4964
2023 Q3	$1.84K	Hold	21,210	–	–	﹤0.01%	4681
2023 Q2	$11.9K	Hold	21,210	–	–	﹤0.01%	4547
2023 Q1	$24.2K	Buy	+21,210	New	+$25.5K	﹤0.01%	4389

Other funds holding RVLP

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

RJA

Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

LPL Financial's RVLP Position: Q4 2023 in Review

LPL Financial sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2023, closing a stake of 21,210 shares — an estimated $1.84K sold.

LPL Financial first reported a position in RVLP in Q1 2023 and held it in 3 quarters. The position peaked at $24.2K in Q1 2023. 3 funds tracked by Wall St. Rank hold RVLP as of Q4 2023.

LPL Financial reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2023 after selling out during the quarter.
LPL Financial sold 21,210 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2023, an estimated $1.84K.
LPL Financial first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q1 2023 and held it in 3 quarters.
LPL Financial's RVL Pharmaceuticals plc Ordinary Shares position peaked at $24.2K in Q1 2023.
3 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2023.

Based on LPL Financial's 13F filing for Q4 2023, filed 14 Feb 2024.